Rezolute, Inc. — Investor Relations & Filings
Filings indexed
721
across all filing types
Latest filing
2026-05-12
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
RZLT
Rezolute, Inc. is a late-stage biopharmaceutical company dedicated to developing therapies for rare diseases. The company's primary focus is on addressing hypoglycemia caused by hyperinsulinism (HI). Its lead product candidate, ersodetug, is being developed as a potential treatment for hypoglycemia related to both congenital and tumor-induced hyperinsulinism. Rezolute is advancing ersodetug through two ongoing Phase 3 clinical trials for these indications, aiming to provide a novel therapeutic option for patients with significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Rezolute, Inc. (0001509261) (Filer) | 2026-05-12 | English | |
| SCHEDULE 13G/A - Rezolute, Inc. (0001509261) (Subject) | 2026-03-26 | English | |
| 8-K - Rezolute, Inc. (0001509261) (Filer) | 2026-03-24 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| 8-K - REZOLUTE, INC. (0001509261) (Filer) | 2026-02-12 | English | |
| 10-Q Filing | 2026-02-12 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 45339564 | 10-Q - Rezolute, Inc. (0001509261) (Filer) | 2026-05-12 | English | ||
| 33050165 | SCHEDULE 13G/A - Rezolute, Inc. (0001509261) (Subject) | 2026-03-26 | English | ||
| 33028716 | 8-K - Rezolute, Inc. (0001509261) (Filer) | 2026-03-24 | English | ||
| 30226787 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 32892933 | 8-K - REZOLUTE, INC. (0001509261) (Filer) | 2026-02-12 | English | ||
| 30226912 | 10-Q Filing | 2026-02-12 | English | ||
| 30226767 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 12414222 | Major Shareholding Notification 2026 | 2026-01-08 | English | ||
| 12414221 | FORM 8-K | 2026-01-07 | English | ||
|
2025
6 filings
| |||||
| 12414223 | Major Shareholding Notification 2025 | 2025-12-19 | English | ||
| 12414224 | Major Shareholding Notification 2025 | 2025-12-18 | English | ||
| 12414225 | FORM 4 | 2025-12-17 | English | ||
| 12414226 | FORM 4 | 2025-12-17 | English | ||
| 12414227 | FORM 4 | 2025-12-16 | English | ||
| 12414228 | FORM 4 | 2025-12-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BioNTech SE
Biotechnology company developing immunotherapies for cancer…
|
BNTX | DE | Manufacturing |
|
BioNxt Solutions Inc.
Clinical-stage developer of next-generation drug formulatio…
|
BNXT | CA | Manufacturing |
|
Biophage Pharma Inc.
Developing innovative phage-based therapies for antibiotic-…
|
BIPMF | CA | Manufacturing |
|
BioPorto
An in vitro diagnostics company specializing in biomarkers …
|
BIOPOR | DK | Manufacturing |
|
BIO-RAD LABORATORIES, INC.
Develops and manufactures products for life science and cli…
|
BIO | US | Manufacturing |
|
Biosergen AB
Develops drugs to treat severe and resistant invasive funga…
|
BIOSGN | SE | Manufacturing |
|
Biosino Bio-Technology and Science Incorporation
Major high-tech manufacturer of in-vitro diagnostic (IVD) p…
|
8247 | HK | Manufacturing |
|
BIOSIS GROUP BERHAD
Manufacturer of pharmaceutical, personal care, skincare, an…
|
— | MY | Manufacturing |
|
Bio Solution Co.,Ltd.
Develops cell therapies, human tissue models, and bio-labor…
|
086820 | KR | Manufacturing |
|
BioSyent Inc.
Specialty pharmaceutical company developing and commerciali…
|
RX | CA | Manufacturing |
Rezolute, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32362/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32362 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32362 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32362 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32362}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Rezolute, Inc. (id: 32362)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.